Nexina Cdcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-10-2024
- Paid Up Capital ₹ 0.10 M
as on 27-10-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 797.42%
(FY 2023)
- Profit -12.02%
(FY 2023)
- Ebitda -10.13%
(FY 2023)
- Net Worth -123.22%
(FY 2023)
- Total Assets 41.03%
(FY 2023)
About Nexina Cdcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yogendra Parashar, Vanita Parashar, Nidhi Awasthi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MP2021PTC058048
- Company No.
058048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2021
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nexina Cdcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogendra Parashar  | Director | 21-Oct-2021 | Current |
| Vanita Parashar | Director | 21-Oct-2021 | Current |
| Nidhi Awasthi | Director | 15-Oct-2022 | Current |
| Sadhana Tiwari | Director | 21-Oct-2021 | Current |
Financial Performance of Nexina Cdcare.
Nexina Cdcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 797.42% increase. The company also saw a substantial fall in profitability, with a 12.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexina Cdcare?
Unlock access to Nexina Cdcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nexina Life Sciences Private LimitedActive 6 years 3 months
Yogendra Parashar, Vanita Parashar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nexina Cdcare?
Nexina Cdcare has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexina Cdcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexina Cdcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
